Losing weight is a goal for many, yet finding the right path can be overwhelming with the myriad of options available today. Two popular medications often discussed in the weight-loss community are Contrave and Wegovy. Both have shown remarkable results in clinical studies, but their mechanisms, side effects, and costs vary. This article dives into a comprehensive comparison, offering insights to help you choose the right solution for your weight-loss journey.
Contrave is a prescription medication combining two active ingredients: Naltrexone and Bupropion. These components work together to control hunger and reduce cravings, making it easier for users to maintain a calorie deficit. Naltrexone targets the brain’s reward system, curbing emotional and compulsive eating, while Bupropion enhances energy and mood, helping individuals stay motivated.
A clinical study revealed significant results for Contrave users. By week 28, 55.6% of participants lost at least 5% of their body weight, compared to 17.5% in the placebo group. By the end of week 56, these numbers were 50.5% for Contrave users and 17.1% for those on a placebo. In addition to weight loss, participants reported improved heart health, healthier eating habits, and a better overall quality of life [1].
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the hormone regulating appetite and digestion. By slowing gastric emptying, Wegovy helps users feel fuller for longer, reducing calorie intake.
In a study, Wegovy users lost an impressive 14.91% of their starting weight over 68 weeks. Those who continued using Wegovy for two years saw sustained success, shedding 15.42% of their initial weight. Its effectiveness has made it a go-to option for individuals looking to achieve substantial weight loss with long-term results [2].
While both medications deliver significant weight loss, their results and timelines differ:
Both medications emphasize the importance of a healthy lifestyle, including diet and exercise, to maximize outcomes.
According to one study, Contrave’s combination of Naltrexone SR and Bupropion SR can lead to:
Some users may experience temporary increases in blood pressure by 1.5 mm Hg, though long-term use generally improves blood pressure levels [3].
Wegovy’s GLP-1 receptor agonist properties can influence digestion and blood sugar levels, leading to:
Close monitoring is crucial, especially for individuals with diabetes or those taking multiple medications.
Contrave offers an affordable option through its Access Program, allowing users to receive the medication for $99 per month via mail-order pharmacy. Insurance coverage may reduce this cost further.
Wegovy is generally more expensive. Without insurance, the cost can exceed $1,000 per month. However, with a discount card, users can save significantly:
Budget considerations play a significant role in choosing the right medication.
While the idea of combining medications for enhanced weight loss may seem appealing, it’s crucial to consult with a healthcare provider. Contrave and Wegovy work differently and may have overlapping side effects, making simultaneous use potentially unsafe. A professional evaluation can determine the best course of action based on your health profile.
Mounjaro, like Wegovy, is a GLP-1 receptor agonist but with additional properties that target dual hormone receptors. This dual action makes Mounjaro potentially more effective for weight loss, though it’s still under research for FDA approval specifically for this purpose. Contrave, on the other hand, is already approved and has a proven track record.
Saxenda is another GLP-1 receptor agonist, similar to Wegovy, but requires daily injections instead of weekly ones. While Saxenda provides effective weight-loss results, Contrave may be a preferable choice for individuals seeking a non-injectable option with similar efficacy.
Phentermine is a stimulant-based weight-loss medication that suppresses appetite. While it’s effective for short-term use, it’s not suitable for long-term weight management due to potential dependency and side effects. Contrave’s dual-action mechanism offers a safer and more sustainable approach.
Choosing between Contrave and Wegovy boils down to your individual needs, health conditions, and weight-loss goals. Contrave is an excellent choice for those seeking gradual, sustainable results with the convenience of a pill, while Wegovy’s dramatic outcomes make it ideal for those aiming for significant weight loss.
If you’re uncertain about which medication aligns with your journey, a consultation with a weight-loss specialist can provide personalized recommendations. At our Weight Loss Clinic, we’re dedicated to helping you achieve your health and wellness goals. Book your consultation today and take the first step toward a healthier, happier you.
Are you ready to transform your weight-loss journey? Contact us now to explore your options and find the solution that’s perfect for you!
1. Apovian CM, Aronne L, Rubino D, et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II). Obesity. 2013;21(5):935-943. doi:https://doi.org/10.1002/oby.20309
2. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002. doi:https://doi.org/10.1056/nejmoa2032183
3. Ornellas T, Chavez B. Naltrexone SR/Bupropion SR (Contrave): A New Approach to Weight Loss in Obese Adults. P T. 2011;36(5):255-262.4. Pharmaceutical Research: Recent Advances and Trends Vol. 6.; 2024. doi:https://doi.org/10.9734/bpi/prrat/v6